Domestic pharmaceutical giant and the big three together! Break through the import encirclement!

Medical doctors participate in product innovation is becoming a new trend, which is particularly evident in the medical device industry.

In September 2017, a large-scale cooperation between China's medical institutions and enterprises of the research project officially closed.

Domestic medical equipment leader - Shenzhen Mindray Biomedical Electronics Co., Ltd. (referred to as 'Mindray'), and Shanghai Ruijin hospital Professor Zhan Weifei, Professor Zhou Jianqiao co-operation, successfully developed based on dual-mode elastic imaging technology shell, shear modulus and other global first flexible intelligent tools.

In addition, Mindray also joined hands with Ruijin Hospital to jointly develop the multi-center research project of Mindi dual-mode elastic imaging of the 16 largest hospitals in China.

17 hospital clinicians, in addition to work, out of time to collect and collate cases, data, successfully collected nearly 5000 cases of breast and thyroid positive cases from all over the country.According to this, the establishment of China's first ultrasound clinical diagnosis standard.

Elastic imaging technology is a new technology, both at home and abroad are not yet popular, master the technology of the enterprise rare. Mindray is the first and only master dual-mode elastic imaging of the enterprise.

Through direct cooperation with first-line doctors to solve their clinical pain points, Mindray opened a new play: to 'business-oriented, joint clinical experts' production, learning, research collaborative innovation model.

In addition to the above thyroid and mammography ultrasound intelligence tool, the results of this new play are:

Mindray and Shenzhen Second People's Hospital, Wang Huifang, director of the joint development of intelligent pelvic floor solution Smart Pelvic, set the customization function, to solve the conventional pelvic ultrasound examination of the clinician time and effort, complex operation, difficult to hand pain.

Mindray and Shenzhen First People's Hospital Dr. Xiong Yi jointly developed the 'obstacle automatic volume navigation Smart Planes' intelligent application, the fetal brain screening from nearly ten minutes to a few seconds, but also reduces the requirements of the doctor's approach, So that the younger doctors can easily play the fetal craniotomy and draw the intracranial structure of the measured value.

It is reported that these intelligent applications and products, are China's first, but also the world's leading.

After the introduction of the 'Smart Planes', there are three young doctors in the hospital said that they had a few years ago to the import manufacturers to mention fetal clinical examination of the brain pain, but a few years have not received any feedback, the demand for the sea. Think of the last to do, is the Chinese brand.

Import manufacturers do not want to dry in China is also difficult to take into account the things, made dry, in turn, China will import the formation of new competitive pressures.

In the past 20 years, Mindray from the past proxy Imports, to their own research and development, engage in mergers and acquisitions, product line more and more widely, has been across the custody, anesthesia, ultrasound, in vitro diagnosis and other fields, and many market share ahead, but also out of the country, nearly half of the products sold to Europe and the United States.

But it is undeniable that in the domestic medical market, domestic to go beyond the key import is still a large hospital.Change the long-term development of the monopoly situation, the use of large hospitals to choose the penetration of doctors, is not so easy to be broken. Technical barriers, but also psychological barriers.

Obviously, in 2016 from the US stock delisting, determined to return to A shares at the same time, Mindray is also looking for domestic junior, catch up with the new way of imports.

This kind of 'enterprise-led, joint clinical experts' research and innovation of the road, in the promotion of Chinese enterprises to high-end intelligent market, to accelerate domestic imports of imports, or will drive the industry gradually to the upper reaches of the value chain.

From another point of view, clinicians participate in product innovation, not only the clinical needs are met, their value has also been greatly released.

medical instruments Finally for the hospital, the patient service, medical equipment innovation, can not be separated from the support of clinicians, only the combination of clinical needs, can really solve the problem.

The new medical reform requires the cut off the gray interest chain of doctors and medicine products, but also encourages clinicians to participate in the technical innovation activities of medicine and medicine, which is plainly written to encourage the innovation of drugs 36 countries inside.

With Chinese medicine enterprise The rise of innovation and research and development is an unprecedented emphasis and desire, Chinese doctors are also facing unprecedented new opportunities.

It is foreseeable that the doctors and enterprises together, doctors involved in drug product innovation, will also be like a doctor, like a hot trend and a big trend!